Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma
- Resource Type
- Article
- Authors
- Dickinson, Michael ; Briones, Javier; Herrera, Alex F.; González-Barca, Eva; Ghosh, Nilanjan; Cordoba, Raul; Rutherford, Sarah C.; Bournazou, Eirini; Labriola-Tompkins, Emily; Franjkovic, Izolda; Chesne, Evelyne; Brouwer-Visser, Jurriaan; Lechner, Katharina; Brennan, Barbara; Nüesch, Eveline; DeMario, Mark; Rüttinger, Dominik; Kornacker, Martin; Hutchings, Martin
- Source
- In Blood Advances 23 November 2021 5(22):4762-4770
- Subject
- Language
- ISSN
- 2473-9529